Exchange: NASDAQ·Updated 09:31 AM EDT
GH logo

GH Guardant Health Inc

$157.37
$0.515
(0.33%)
Today
EarningsNov 5
Mkt Cap$21.19B
Vol4,813.00

About GH

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.
43

Bearish Sentiment

How do you feel about GH?

Gator5326
$GH if you believe put your head down and ride the action. No bad news, no bad reports, just a coordinated bear attack in this sector. The numbers will keep us rolling. 😎
4
healthcareguru
$GH with this positive $GRAL FDA panel vote, GH should be up 20-30%+ tmrw as it lowers the bar for them at the FDA and they have a better test. 🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥 $XLV $IWM $XBI
3
GoldenBum77
$GH There is nothing happening here except profit taking and a huge opportunity to get in if you’re not already, and if you are in, to get in deeper. Early Cancer detection is becoming big money and GH is the leading provider. Prediction $200 before EOY
2
evanmedeiros
Not everything working in this market needs an AI story. Guardant Health $GH is up 80% YTD and making a run at all-time highs. Strong trend, clean structure, and still not overly extended. Seen here on MarketSurge. I am long. #IBDPartner
2
Albino_Trader123
$GH This turtle been treading flat base for months. Coiling still. 180-181ish on volume trigger
2
Gator5326
$GH Taking market share like a boss! So many facets moving at warp speed hang on with both hand! 😎
1
Gator5326
$GH “For the first time, we’ve been able to correlate the impact of real-world follow-up colonoscopies and screening adherence with the modeling studies of the Shield blood test. We're proud to present this compelling research with our collaborators at ACG and to continue to demonstrate Shield’s role as a clinically meaningful alternative to traditional screening methods.” 😎😎😎
1
Albino_Trader123
$GH Damn annoying stock finally broke out today from entry last week. Looking good breaking out from 3 months of chop. Entries back in late June and last week alerted

Advertisement|Remove ads.